United States· US:17156-067_4fda8ebc-b46e-4d12-9c45-8cbb3a2516bb
Vizamyl
A medicinal product containing flutemetamol f-18, registered in United States by GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare).
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLUTEMETAMOL F-18
- Manufacturer
- GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1117156067301 VIAL, MULTI-DOSE in 1 CONTAINER (17156-067-30) / 30 mL in 1 VIAL, MULTI-DOSE
- ndc1117156-067-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flutemetamol f-18 in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVIZAMYLGE Healthcare AS, Oslo
- SpainVIZAMYL 400 MBq/ml solucion inyectable Flutemetamol (18F)Ge Healthcare As
- FinlandVizamylGE Healthcare AS
- FranceVIZAMYL 400 MBq/ml, solution injectableGE HEALTHCARE (NORVEGE)
- IrelandVIZAMYL 400 MBq/mL solution for injectionGE Healthcare AS
- NetherlandsVIZAMYL 400 MBq/ml oplossing voor injectieGE Healthcare AS
- SwedenVIZAMYL 400 MBq/ml Injektionsvätska, lösningGE Healthcare AS
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vizamyl
- Iceland · Vizamyl
- Liechtenstein · Vizamyl
- Norway · Vizamyl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ab722dd-23df-4256-8141-d723d6233085 GET /v1/drugs/1ab722dd-23df-4256-8141-d723d6233085?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "4.05",
"substance": "FLUTEMETAMOL F-18",
"productndc": "17156-067",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mCi/mL",
"application_number": "NDA203137",
"marketing_category": "NDA"
}See everything about flutemetamol f-18.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.